HealthMore in Health→
Ultra-low dosing could widen access to expensive cancer care
Key Takeaways
- STAT reports that ultra-low doses could expand access to costly cancer treatments.
- The access implications are especially significant for poorer countries.
- Dose strategy can affect affordability, supply and treatment capacity.
- Adoption would depend on strong evidence that lower dosing preserves clinical benefit.
DE
DT Editorial Team··via statnews.com